E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)
10 November 2025
3 mins read

E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

Updated: November 10, 2025 — Nationwide (France)

Key points at a glance

  • Two Reblochon de Savoie AOP references recalled today for E. coli STEC O26 contamination: E.Leclerc’s “Nos Régions ont du Talent” and the Masson Reblochon sold at Grand Frais and Fresh. Rappel Consommateur
  • Do not consume these cheeses; return or destroy as instructed. Refunds are available. Rappel Consommateur
  • Lots & dates to check now:
    • Leclerc: lots 5-258 (DLC 06/01/2026) and 5-258V (DLC 04/12/2025), GTIN 3564709021249. Sold 03/10/2025–07/11/2025. Rappel Consommateur
    • Grand Frais/Fresh (Masson): lot 5-258V, DLC 02/11/2025–06/01/2026, sold 22/10/2025–31/10/2025. Rappel Consommateur
  • Recall windows: until November 26, 2025 (Leclerc) and November 21, 2025 (Grand Frais/Fresh). Rappel Consommateur

What’s being recalled today

1) E.Leclerc — “Nos Régions ont du Talent”

  • Products: Reblochon de Savoie AOP 28% MG 450 g and ½ Reblochon 240 g.
  • Lots/DLC: 5-258 (DLC 06/01/2026) and 5-258V (DLC 04/12/2025).
  • GTIN: 3564709021249 (prepacked).
  • Health mark: FR 74.145.050 UE.
  • Sold: France entière, 03/10/2025–07/11/2025 (cut-to-order at the counter and in prepacked “LS”).
  • Reason: Presence of E. coli STEC O26.
  • Action: Do not consume; return to the store; contact customer service; refund provided.
  • End of recall procedure: Wednesday, November 26, 2025. Rappel Consommateur

2) Grand Frais & Fresh — Reblochon de Savoie AOP (Masson)

  • Product: Reblochon de Savoie AOP Masson (listed “Sans marque” on the recall form).
  • Lot/DLC: 5-258V, DLC range 02/11/2025–06/01/2026.
  • Health mark: FR 74.145.050 CE.
  • Conditioning: whole cheese under paper or sliced under film.
  • Sold: France entière, 22/10/2025–31/10/2025.
  • Reason: Detection of E. coli STEC O26.
  • Action: Do not consume; destroy the product or follow store instructions; refund provided.
  • End of recall procedure: Friday, November 21, 2025. Rappel Consommateur

How to spot the right product quickly: Check the brand, lot number, DLC (use-by date), GTIN (barcode), and the oval health stamp (FR 74.145.050). If any of these match the details above, treat the cheese as affected by the recall. Rappel Consommateur


Why are these cheeses recalled?

The two recalls were issued after the presence/detection of E. coli STEC O26 was identified. Shiga toxin–producing E. coli can cause diarrhea (sometimes bloody), abdominal pain, and vomiting, possibly with fever. Severe kidney complications (HUS) can occur in 5–8% of cases, particularly in children. Rappel Consommateur


What to do if you bought these Reblochons

  1. Do not consume the cheese — even cooked preparations are not recommended when a recall instructs non-consumption. Follow the official guidance. Rappel Consommateur
  2. Return it to the point of purchase or destroy it as indicated; a refund is offered. Rappel Consommateur
  3. Monitor your health for a week after any potential consumption: watch for bloody diarrhea, stomach cramps, vomiting, and fever. Seek medical advice promptly and mention the product, purchase place and date. If no symptoms occur within 15 days, it is not necessary to consult, per official guidance. Rappel Consommateur
  4. Leclerc consumer line (for the private-label product): 0 800 874 187 (free call). Rappel Consommateur

Where and when were they sold?

  • Nationwide (France entière).
  • E.Leclerc products were sold October 3 to November 7, 2025; Grand Frais/Fresh (Masson) products were sold October 22 to October 31, 2025. Rappel Consommateur

Recall timelines and deadlines

  • Grand Frais/Fresh (Masson): recall runs through Friday, November 21, 2025.
  • E.Leclerc — “Nos Régions ont du Talent”: recall runs through Wednesday, November 26, 2025. Rappel Consommateur

Who is most at risk?

Children, older adults, immunocompromised individuals, and pregnant people are considered more vulnerable to STEC infections. As a general precaution, authorities remind consumers to avoid raw milk and cheeses made from raw milk in high‑risk groups and to practice strict food hygiene. Rappel Consommateur


Can I still eat Reblochon if it’s not from these lots?

Yes—this recall targets specific lots and brands listed above. If your cheese does not match the brand, lot, DLC, GTIN, or health stamp, it is not part of today’s recall. When in doubt, check the official RappelConso database and your store’s customer service desk. Rappel Consommateur


Sources (official and corroborating)

  • RappelConso (French Government) — “Nos Régions ont du Talent” Reblochon de Savoie AOP recall notice (fiche 2025‑11‑0058). Rappel Consommateur
  • RappelConso (French Government) — Masson Reblochon de Savoie AOP recall notice (fiche 2025‑11‑0057). Rappel Consommateur
  • Category overview listing both recalls for verification. Rappel Consommateur
  • Consumer press summaries (for context and visibility across retailers): Doctissimo and AlloDocteurs coverage on November 10, 2025. Doctissimo

Editor’s note for readers

If you spot an affected product still on shelves, report it via SignalConso (government platform linked on the recall pages). For ongoing updates, consult RappelConso directly and follow retailer notices at your local store. Rappel Consommateur


SEO tags (suggested): Reblochon recall, E. coli O26, Nos Régions ont du Talent, Leclerc recall, Grand Frais recall, Fresh recall, Masson Reblochon, Rappel Conso, France food safety, fromage au lait cru

Stock Market Today

  • Trevi Therapeutics (TRVI) valuation under scrutiny after FDA End of Phase 2 update
    January 11, 2026, 6:56 PM EST. Trevi Therapeutics (TRVI) trades near $11.18 after updating investors on an FDA End of Phase 2 meeting for its chronic cough program in idiopathic pulmonary fibrosis. The stock shows mixed momentum: 30-day return down 12.45%, 90-day gain 15.14%, and 1-year total shareholder return around 192.67%. With analyst targets in the high teens to low $20s, the question is whether the stock remains at a premium. On price-to-book (P/B), the multiple is 7.6x versus ~2.6x for the US Pharmaceuticals group and ~6.8x for peers, signaling an overvalued stance. The company has US$0 revenue and a net loss of US$45.86 million, leaving little room if trial readouts disappoint or funding tightens. Risks: clinical setbacks, tougher capital markets.
Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)
Previous Story

Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside
Next Story

CSU Stock Today (Nov 10, 2025): Constellation Software Hits New 52‑Week Low as BMO Trims Target; Q3 Revenue +16% and $1 Dividend Reaffirmed

Go toTop